Levin Capital Strategies’s BioAmber Inc. BIOA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-239,854
| Closed | -$10K | – | 365 |
|
|
2017
Q1 | $10K | Sell |
239,854
-30,162
| -11% | -$8.76K | ﹤0.01% | 301 |
|
|
2016
Q4 | $189K | Sell |
270,016
-20,206
| -7% | -$9.38K | ﹤0.01% | 279 |
|
|
2016
Q3 | $137 | Sell |
290,222
-25,380
| -8% | -$10.7K | ﹤0.01% | 312 |
|
|
2016
Q2 | $111K | Hold |
315,602
| – | – | ﹤0.01% | 321 |
|
|
2016
Q1 | $574K | Sell |
315,602
-15,935
| -5% | -$23.8K | 0.01% | 213 |
|
|
2015
Q4 | $468K | Buy |
331,537
+30,066
| +10% | +$52.1K | 0.01% | 257 |
|
|
2015
Q3 | $536K | Buy |
301,471
+105,650
| +54% | +$199K | 0.01% | 247 |
|
|
2015
Q2 | $386K | Buy |
195,821
+18,671
| +11% | +$36.7K | 0.01% | 296 |
|
|
2015
Q1 | $282K | Hold |
177,150
| – | – | ﹤0.01% | 333 |
|
|
2014
Q4 | $289K | Buy |
177,150
+12,150
| +7% | +$24.4K | ﹤0.01% | 334 |
|
|
2014
Q3 | $389K | Hold |
165,000
| – | – | 0.01% | 280 |
|
|
2014
Q2 | $408K | Hold |
165,000
| – | – | 0.01% | 287 |
|
|
2014
Q1 | $360K | Hold |
165,000
| – | – | 0.01% | 281 |
|
|
2013
Q4 | $120K | Hold |
165,000
| – | – | ﹤0.01% | 316 |
|
|
2013
Q3 | $115K | Hold |
165,000
| – | – | ﹤0.01% | 299 |
|
|
2013
Q2 | $91K | Buy |
+165,000
| New | +$105K | ﹤0.01% | 314 |
|
Levin Capital Strategies's BIOA.WS Position: Q2 2017 in Review
Levin Capital Strategies sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 239,854 shares — an estimated $10K sold.
Levin Capital Strategies first reported a position in BIOA.WS in Q2 2013 and held it in 16 quarters. The position peaked at $574K in Q1 2016. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.
- Levin Capital Strategies reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
- Levin Capital Strategies sold 239,854 BioAmber Inc. shares in Q2 2017, an estimated $10K.
- Levin Capital Strategies first reported a position in BioAmber Inc. in Q2 2013 and held it in 16 quarters.
- Levin Capital Strategies's BioAmber Inc. position peaked at $574K in Q1 2016.
- 0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.
Based on Levin Capital Strategies's 13F filing for Q2 2017, filed 11 Aug 2017.